| Code | Description | Claims | Beneficiaries | Total Paid |
| T1015 |
Clinic visit/encounter, all-inclusive |
21,830 |
16,533 |
$1.98M |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
279 |
184 |
$18K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
150 |
89 |
$917.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,710 |
8,991 |
$844.20 |
| 90686 |
|
72 |
40 |
$718.28 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,942 |
5,476 |
$371.53 |
| 80305 |
|
79 |
41 |
$219.84 |
| 82948 |
|
21 |
12 |
$43.23 |
| 3008F |
|
171 |
150 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
16 |
12 |
$0.00 |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
55 |
39 |
$0.00 |
| 4010F |
|
54 |
44 |
$0.00 |
| 3075F |
|
32 |
31 |
$0.00 |
| 1036F |
|
119 |
98 |
$0.00 |
| 3074F |
|
115 |
101 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
17 |
15 |
$0.00 |
| 3080F |
|
44 |
31 |
$0.00 |
| 3079F |
|
85 |
80 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
33 |
26 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
20 |
14 |
$0.00 |
| 3078F |
|
56 |
53 |
$0.00 |
| 1160F |
|
244 |
208 |
$0.00 |
| 3077F |
|
17 |
15 |
$0.00 |
| 1159F |
|
243 |
208 |
$0.00 |